1.Patwardhan, RV, Nanda, A. Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery 2005;56:139–144.
2.Schoenbaum, SC, Gardner, P, Shillito, J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 1975;131:543–552.
3.McLone, D, Czyzewski, D, Raimondi, A, Sommers, R. Central nervous system infections as a limiting factor in the intelligence of children with myelomeningocoele. Pediatrics 1982;70:338–342.
4.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.
5.Horan, TC, Gaynes, RP, Martone, WJ, Jarvis, WR, Emori, TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606–608.
6.Thompson, DN, Hartley, JC, Hayward, RD. Shunt infection: is there a near-miss scenario? J Neurosurg 2007;106(1 Suppl):15–19.
7.Choux, M, Genitori, L, Lang, D, Lena, G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992;77:875–880.
8.Mottolese, C, Grando, J, Convert, J, et al.Zero rate of shunt infection in the first postoperative year in children—dream or reality? Childs Nerv Syst 2000;16:210–212.
9.Ratilai, B, Costa, J, Sampaio, C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a. systematic review. J Neurosurg Pediatrics 2008;1:48–56.
10.Bratzier, DW, Houck, PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005;189:395–404.